Why Invitae Stock Plummeted by 15% Today

Motley Fool2022-06-03

What happened Genetic medical testing specialist Invitae (NVTA -15.17%) didn't pass the investment test for one researcher late on Thursday. The following day its stock took a more than 15% hit ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

coolstuff
2022-06-06
coolstuff
Die already.. go catch a falling knife..

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2240208955?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-06-03 00:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2240208955","market":"us","top_or_hot":-1,"title":"Why Invitae Stock Plummeted by 15% Today","media":"Motley Fool","content":"<div>\n<p>What happened\nGenetic medical testing specialist Invitae (NVTA -15.17%) didn't pass the investment test for one researcher late on Thursday. The following day its stock took a more than 15% hit ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/06/03/why-invitae-stock-plummeted-by-15-today/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Invitae Stock Plummeted by 15% Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Invitae Stock Plummeted by 15% Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-03 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/06/03/why-invitae-stock-plummeted-by-15-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nGenetic medical testing specialist Invitae (NVTA -15.17%) didn't pass the investment test for one researcher late on Thursday. The following day its stock took a more than 15% hit ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/06/03/why-invitae-stock-plummeted-by-15-today/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVTA","symbol_name":"Invitae Corporation","start_time":0,"source_url":"https://www.fool.com/investing/2022/06/03/why-invitae-stock-plummeted-by-15-today/","article_id":"2240208955","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2240208955","pubTimestamp":1654185600,"columns":[],"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"Investors are taking a new, bearish analyst view on the company to heart.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVTA":"Invitae Corporation","BK4196":"保健护理服务","BK4139":"生物科技"},"translate_title":"为什么Invitae股票今天暴跌15%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVTA":1},"content_text":"What happened\nGenetic medical testing specialist Invitae (NVTA -15.17%) didn't pass the investment test for one researcher late on Thursday. The following day its stock took a more than 15% hit because of this estimation. \nSo what\nAfter market hours on Thursday, financial services company Piper Sandler initiated coverage of Invitae stock. That wasn't necessarily beneficial for the biotech, as analyst David Westenberg rated the stock an underweight (i.e., sell) at a price target of $2.50 per share. Even after that 15% price dive, Invitae still trades at a rich level for Westenberg, at just over $3.\n\nImage source: Getty Images.\n\n\"We think germline testing is becoming more commoditized and Invitae has a late start to somatic cancer,\" the prognosticator wrote in a research note, referring to two types of genetic screening for cancer.\n\"We model numbers below the Street,\" he added. Those estimates were not immediately available.\nOnly a clutch of analysts track Invitae. Some are more bullish than Westenberg on the company's prospects; on average, they're expecting the company to lift its total sales by 36% year over year in 2022, and another 35% next year. They are also collectively modeling a narrower per-share net loss for 2023.\n\n\n\n\nNow what\nInvestors tend to be sensitive about takes like Westenberg's, since the typical biotech is heavily dependent on its core technology, or one (or very few) pipeline product(s). Not unusually for such a company, Invitae is also chronically unprofitable and is burning through its cash at a fairly quick rate. \nIt's no wonder, then, that the stock is now touching all-time lows. Analyses such as the new Piper Sandler take won't help the situation.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9053877854,"gmtCreate":1654523746278,"gmtModify":1676535462156,"author":{"id":"3575813982420697","authorId":"3575813982420697","name":"coolstuff","avatar":"https://static.tigerbbs.com/59416cd904d3254185c947646f5920b9","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3575813982420697","idStr":"3575813982420697"},"htmlText":"Die already..&nbsp; go catch a falling knife..&nbsp;&nbsp;","listText":"Die already..&nbsp; go catch a falling knife..&nbsp;&nbsp;","text":"Die already.. go catch a falling knife..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9053877854","repostId":2240208955,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2240208955"}